What are the clinical features of Peutz-Jeghers syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Features of Peutz-Jeghers Syndrome

Peutz-Jeghers syndrome (PJS) is an autosomal dominant disorder characterized by distinctive mucocutaneous melanin pigmentation and hamartomatous polyps throughout the gastrointestinal tract, with a 93% lifetime risk of developing cancer. 1

Key Diagnostic Features

Mucocutaneous Pigmentation

  • Present in >95% of affected patients 1
  • Dark brown or blue-brown melanotic pigmented macules (1-5 mm in size)
  • Typically appears in infancy and may fade during late adolescence 2
  • Distribution pattern:
    • Vermilion border of the lips (94% of patients)
    • Buccal mucosa (66%)
    • Hands (74%)
    • Feet (62%)
    • Periorbital, perianal, and genital regions 1
  • Important distinction: Unlike freckles, PJS pigmentation occurs on the buccal mucosa and around nostrils/mouth 2

Gastrointestinal Hamartomatous Polyps

  • True hamartomas with unique histopathologic characteristics:
    • Frond-like structure
    • Branching framework of connective tissue and smooth muscle
    • Lined by normal intestinal epithelium rich in goblet cells
    • Elongated and convoluted glands with arborizing growth pattern 2
  • Distribution:
    • Small intestine (64%)
    • Colon (64%)
    • Stomach (49%)
    • Rectum (32%) 1

Common Complications

  • Gastrointestinal bleeding (acute or chronic)
  • Small bowel intussusception
  • Intestinal obstruction 3, 4
  • These complications often require emergency surgical intervention 5

Genetic Basis

  • Caused by germline mutations in the STK11/LKB1 gene on chromosome 19p13.3
  • STK11 functions as a tumor suppressor gene encoding a serine/threonine kinase
  • Mutations detected in 66-94% of PJS cases 1
  • Inheritance pattern: autosomal dominant with incomplete penetrance and variable expression 2

Cancer Risk

  • Overall relative risk: 15.2 times the general population
  • Lifetime risk of any cancer by age 64: 93%
  • Cumulative cancer risk by age 70: 81% 1
  • Specific cancer risks by age 70:
    • Breast (54%)
    • Colon (39%)
    • Pancreas (36%)
    • Stomach (29%)
    • Ovary (21%)
    • Lung (15%)
    • Small intestine (13%)
    • Cervix (10%)
    • Uterus (9%)
    • Testes (9%) 1
  • Rare but characteristic tumors:
    • Sex-cord tumors with annular tubules of the ovary
    • Adenoma malignum of the cervix
    • Testicular tumors of sex-cord and Sertoli-cell type 1, 3

Diagnostic Criteria

PJS diagnosis can be made in patients with:

  • Histologically confirmed hamartomatous polyp(s) plus at least 2 of the following:
    • Labial melanin deposits
    • Family history of the syndrome
    • Small bowel polyposis 2, 1

Clinical Pitfalls to Avoid

  • Misdiagnosis is common - patients often visit hospitals repeatedly before correct diagnosis 5
  • Melanotic spots on the face may be overlooked, leading to missed diagnosis 5
  • Differential diagnosis should include Laugier-Hunziker syndrome, which has similar pigmentation but:
    • Lesions appear in young/middle-aged adults (not infancy)
    • Less periorificial pigmentation
    • May have conjunctival pigmentation and longitudinal melanonychia 2
  • PJS has equal distribution between males and females and occurs in all racial groups, with estimated incidence of 1/50,000 to 1/200,000 live births 2, 1

Early recognition of these characteristic features is crucial for timely diagnosis, appropriate management, and cancer surveillance to reduce morbidity and mortality in affected individuals.

References

Guideline

Peutz-Jeghers Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Peutz-Jeghers syndrome: risks of a hereditary condition.

Scandinavian journal of gastroenterology. Supplement, 1999

Research

Recurrent intestinal obstruction in a patient of Peutz-Jeghers syndrome.

Journal of cancer research and therapeutics, 2019

Research

Peutz-Jeghers Syndrome: Lessons to be Learned in the Clinical Diagnosis.

Journal of Indian Association of Pediatric Surgeons, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.